MADISON, Wis., December 9, 2022 – Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for its breast cancer radiation signature, Profile for the Omission of Local Adjuvant Radiotherapy (POLAR), at the 2022 San Antonio Breast Cancer Symposium® (SABCS®). The meta-analysis of three independent, randomized clinical trials identified which early-stage breast cancer patients benefited from radiotherapy after breast-conserving surgery.
Author Archive: AZBio
It’s Time to Apply for Venture Madness 2023
The deadline to apply is Thursday, Jan. 12, 2023 at 3 PM MSTContinue reading
It’s Time to Apply for Start-Up Stadium
Start-up Stadium introduces biotech innovators to investors!
Biotech start-ups: apply to pitch your science at the Start-up Stadium during the BIO International Convention, the largest annual gathering of the biotech community, June 5-8 in Boston.Continue reading
Arizona Legislative Leaders Discuss The Road Ahead
In 2023, Arizona will welcome a new governor and a new legislature. Watch the video for insights shared by Arizona’s incoming Senate President Pro Tem and incoming House Democratic Leader as they discuss the road ahead.
Recorded at the AZBio Trailblazers Luncheon on December 15, 2022. Continue reading
$10.8M initiative unites engineering and health researchers to improve cancer treatments
A University of Arizona project, with funding from the state’s New Economy Initiative, creates humanlike cancer models and growth environments to help improve prevention, diagnosis and treatment.Continue reading
Applications Open for Helios Scholars at TGen and TGen Bioscience Leadership Academy.
Do you want to experience what it’s really like to be a scientist?Continue reading
Arizona Center for Cancer Care Marks an Extraordinary Milestone Treating their 100th Patient with GammaTile Therapy for Brain Tumors
GammaTile® Therapy is FDA-cleared as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms, including brain metastases, glioblastomas, and meningiomas.Continue reading
UArizona Health Sciences Researchers Awarded $7.3M to Study Long COVID
The University of Arizona Health Sciences is one of five sites that will be tracking the burden, distribution and impact of post COVID-19 conditions.
Continue reading
Aqualung Therapeutics, an Immunotherapeutics Biotech Company, Receives First $1.5M Toward Series A Preferred Capital Raise; Will Present at 2023 Annual Biotech Showcase
-JSR Lifesciences invested $1.5M toward the preferred series A capital raise, October 2022.
-The dosing of the P1A Healthy Human Volunteer Study with ALT-100 mAb is nearing completion, with no reported SAEs to date. Study to conclude by Q2 2023.Continue reading
TapRoot Partners with Psychiatric Provider Group Peace of Mind Consultants to Use Ella®
TapRoot Interventions & Solutions, Inc (TapRoot) is partnering with psychiatric and behavioral health provider group Peace of Mind Consultants (POMC) in Arizona to provide Ella® to their patients and business partners. Ella is a digital careplan platform that provides interventions to prevent, decrease, and de-escalate dementia-related and mental illness-related behavioral symptoms known to occur in Long Term Care communities. POMC will use Ella to garner key insights from caregiver feedback in order to tailor patient-specific treatment plans and determine appropriate use of medications. The value of the partnership is a provider service model coupled with a caregiver platform to assess, evaluate, and provide outcome measures to improve overall resident care.Continue reading